Immunotherapy in Nonendemic Nasopharyngeal Carcinoma: Real-World Data from Two Nonendemic RegionsPanagiota Economopoulou, Paolo Bossi, Anastasios Kyriazoglou et al.|Cells|2021Cited by 11
Long-lasting responses with chemotherapy followed by T-cell therapy in recurrent or metastatic EBV-related nasopharyngeal carcinomaSimona Secondino, Patrizia Comoli, Paolo Pedrazzoli et al.|Frontiers in Immunology|2023Cited by 5